glp 1 antagonist drugs Chemical structures of GLP-1 receptor antagonists. Representative Patient education tips for GLP-1,
Description
However, the consistency of effect directions across all sensitivity methods (e.g., weighted median, RAPS) and the integration of evidence through meta-analysis strengthen confidence in our primary findings
Depending on the outcome, you may have the opportunity to appeal the decision
Choi RH, Tatum SM, Symons JD, Summers SA, Holland WL
doi:10.2337/db19-54-OR 44
Wahabi HA, Fayed A, Esmaeil S, Elmorshedy H, Titi MA, Amer YS, et al
Conclusion Compared with placebo, GLP-1 RAs may reduce the risk of MACE in patients with HF coexisting with T2DM, with a more significant efficiency of human GLP-1 RAs
